t
On 29 November 2023, Dechra Pharmaceuticals PLC announced that Alison Platt, its Non-Executive Chair, has been appointed as Chair of the Board and Non-Executive Director of Hargreaves Lansdown plc. This new appointment for Ms. Platt is effective in early 2024.
| Date | 29 Nov 2023 |
| Time | 08:17:09 |
| Category | Miscellaneous |
| ID | 0573V |
29 November 2023
Dechra® Pharmaceuticals PLC
(Dechra or the Company)
LEI: 213800J4UVB5OWG8VX82
DIRECTOR DECLARATION
In accordance with Listing Rule 9.6.14(2) Dechra announces that Alison Platt, Non-Executive Chair of Dechra, has been appointed as a Chair of the Board and Non-Executive Director of Hargreaves Lansdown plc in early 2024.
For further information, please contact:
Dechra Pharmaceuticals PLC
Telephone number: +44 (0) 1606 814730
Email: [email protected]
About Dechra
Dechra is a global veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. For more information, please visit: www.dechra.com.
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.